Free Trial

Terumo Co. (OTCMKTS:TRUMY) Short Interest Update

Terumo logo with Medical background

Terumo Co. (OTCMKTS:TRUMY - Get Free Report) was the target of a large decline in short interest in December. As of December 31st, there was short interest totalling 17,200 shares, a decline of 47.4% from the December 15th total of 32,700 shares. Based on an average daily trading volume, of 133,300 shares, the days-to-cover ratio is presently 0.1 days.

Terumo Stock Up 0.7 %

TRUMY stock traded up $0.14 during trading hours on Tuesday, hitting $18.90. The company's stock had a trading volume of 140,301 shares, compared to its average volume of 92,488. The company has a quick ratio of 1.70, a current ratio of 2.94 and a debt-to-equity ratio of 0.12. The company has a market capitalization of $28.17 billion, a PE ratio of 40.02 and a beta of 0.65. Terumo has a 12 month low of $14.06 and a 12 month high of $21.22. The stock has a 50 day moving average price of $19.76 and a two-hundred day moving average price of $18.82.

Terumo Company Profile

(Get Free Report)

Terumo Corporation engages in the manufacture and sale of medical products and equipment in Japan, Europe, China, the United States, Asia, and internationally. The company operates through three segments: Cardiac and Vascular Company, Medical Care Solutions Company, and Blood and Cell Technologies Company.

Recommended Stories

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in Terumo Right Now?

Before you consider Terumo, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Terumo wasn't on the list.

While Terumo currently has a "Hold" rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

20 High-Yield Dividend Stocks that Could Ruin Your Retirement Cover

Almost everyone loves strong dividend-paying stocks, but high yields can signal danger. Discover 20 high-yield dividend stocks paying an unsustainably large percentage of their earnings. Enter your email to get this report and avoid a high-yield dividend trap.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

7 Large-Cap Stocks Headed for Strong, Steady Gains in 2025

7 Large-Cap Stocks Headed for Strong, Steady Gains in 2025

While 2025 may not deliver massive returns, so MarketBeat analyst Chris Markoch shares his list of seven stocks primed for consistent performance.

Recent Videos

Affordable AI Stocks: 7 Picks Under $50
2025 Natural Gas Comeback: 3 Stocks Poised for Big Gains
Why the Latest Jobs Data Has Wall Street Nervous

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines